Abiopharma

News list

Niemiec Steven 🟡 adjusted position in 0 shares (1 derivative) of TechTarget, Inc. (TTGT) Transaction Date: Aug 13, 2026 | Filing ID: 354223

Full text

News bot Aug. 17, 2026, 8:50 p.m.
🔍 Niemiec Steven (Executive)

Company: TechTarget, Inc. (TTGT)

Report Date: 2026-08-13
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 47,187
- Total shares sold: 47,187
Detailed Transactions and Holdings:
- Acquired 47,187 shares of Common Stock (Direct)
  Date: 2026-08-13 | Code: M | equity_swap_involved: false | shares_owned_after: 148,815.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 47,187 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-13 | Code: M | equity_swap_involved: false | shares_owned_after: 47,187.00 | transaction_form_type: 4 | Footnotes: F1, F3, F3
Footnotes:
- F1: This transaction represents the settlement of restricted stock units ("RSUs") in shares of common stock on their scheduled vesting date.
- F2: Each RSU represents a contingent right to receive one share of TechTarget, Inc.'s ("Informa TechTarget") Common Stock upon vesting.
- F3: This award was granted on August 13, 2024. One-third of the RSUs subject to the award vested on each of August 13, 2025 and August 13, 2026, and one-third of the RSUs are scheduled to vest on August 13, 2027. Vested shares will be delivered to the Reporting Person on the applicable dates as set forth in the Reporting Person's award agreement with respect to each vesting tranche.